Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
UPXI · Nasdaq · United States · Finance Services
In shortUPEXI, INC. is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | -963.5% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -984.3% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -1356.3% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -84.0% | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 46.7% | 0/100 |
| Operating margin volatility | 406.3% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -11.8% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 23 | 36 | 26 | 16 | 25 |
| Cost of revenue | 8.2 | 15 | 13 | 4.9 | 2.6 |
| Gross profit | 15 | 21 | 13 | 11 | 22 |
| Operating income | (6.5) | (12) | (22) | (12) | (241) |
| Interest expense | 0 | – | 0.1 | 0.1 | 0.1 |
| Pre-tax income | (6.4) | (17) | (26) | (14) | (246) |
| Income tax | 0.5 | 3 | (0.3) | 0 | 0 |
| Net income | (2) | (17) | (24) | (14) | (246) |
| Diluted EPS | −$0.43 | −$18.94 | −$23.03 | −$1.73 | −$3.87 |
| Diluted shares (millions) | 16 | 0.9 | 1 | 7.9 | 64 |
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of UPEXI, INC. are included in the Investor plan. Try free for 7 days →
Not computed: the model does not apply to banks and insurers.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Sep 17, 2026